PGProcter & Gamble

$161.12+10% 1Y

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though at the top of its own P/E range.

1 to watch, 1 neutral, 1 without data
What the price assumes~+8% a year

Priced for ~8% a year FCF growth. Moderate growth expectations are priced in.

Vs its own P/E rangedearer than 76% of its own historyderived

Expensive vs its own history: P/E 24.3 vs a 22.1 median over 42 quarters (+10% vs median).

Vs sector (EV/EBIT)20.0×

Sector median 17.7× across 76 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Sep 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market
FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What PG's price assumes

Procter & Gamble trades at 24.3× earnings against 24.3× for the median Household & Personal Products name, cheaper than its own group.

24.3

Trailing P/E · Household & Personal Products median 24.3 · cheaper than the typical name in its group

Price / sales
4.25

Price / sales · today's price, trailing year to Sep 30, 2026

Free cash flow yield
4.1%

Free cash flow yield · Household & Personal Products median 5.1%

Growth the price implies
+8.3%

Growth the price implies · The price pays for +8.3% free cash flow growth a year for a decade; the business has delivered +1.7% a year over the last three.

Details›
Price / booktoday's price, trailing year to Sep 30, 2026
6.75
EV / EBITtoday's price, trailing year to Sep 30, 2026
20.0
EV / salestoday's price, trailing year to Sep 30, 2026
4.52
Consumer Defensive median P/E140 names
21.7
Household & Personal Products median P/E18 names
24.3
Free cash flow, trailing twelve months
$15.3B
Market capitalisation2.32 billion shares, counted Sep 30, 2026
$373.4B
3-year revenue growth
+1.8%
3-year free cash flow growth
+1.7%
What the market has paid for these earnings: 42 quarters of its own multiple × $6.64 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$130.45
Its own P/E history, median$146.66
Its own P/E history, upper quartile$160.45
52-week range$136.04 – $165.95
Today$161.12

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.